Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

Hanae Nakashima-Yasuda, Kunihiro Uryu, John Robinson, Sharon X. Xie, Howard Hurtig, John E. Duda, Steven E. Arnold, Andrew Siderowf, Murray Grossman, James B. Leverenz, Randall (Randy) Woltjer, Oscar L. Lopez, Ronald Hamilton, Debby W. Tsuang, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Christopher M. Clark, Thomas J. Montine, Virginia M Y LeeJohn Q. Trojanowski

Research output: Contribution to journalArticle

260 Citations (Scopus)

Abstract

Here, we investigated if TAR-DNA-binding protein-43 (TDP-43), the disease protein in frontotemporal lobar degeneration and ubiquitin inclusions with or without motor neuron disease as well as amyotrophic lateral sclerosis, also formed inclusions in Lewy body (LB) disorders including Parkinson's disease (PD) without or with dementia (PDD), and dementia with LBs (DLB) alone or in association with Alzheimer's disease (AD). Immunohistochemical analyses of TDP-43 in clinically well characterized and pathologically confirmed cases of DLB + AD, PD and PDD demonstrated TDP-43 pathology in the following percentage of cases: DLB + AD = 25/80 (31.3%); PD = 5/69 (7.2%); PDD = 4/21 (19%), while DLB and normal controls exhibited no (0/10, 0%) and one cases (1/33, 3%) presenting TDP-43 pathology, respectively. Significant differences in the prevalence of TDP-43 lesions were noted between disease versus normal brains (P <0.001) as well as demented versus non-demented brains (P <0.001). Statistical analyses revealed a positive relationship between TDP-43 lesions and several clinical and pathological parameters in these disorders suggesting the TDP-43 pathology may have co-morbid effects in LB diseases. This study expands the concept of TDP-43 proteinopathies by implicating TDP-43 lesions in mechanisms of neurodegeneration in LB disorders.

Original languageEnglish (US)
Pages (from-to)221-229
Number of pages9
JournalActa Neuropathologica
Volume114
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Lewy Body Disease
DNA-Binding Proteins
Morbidity
Dementia
Lewy Bodies
Alzheimer Disease
Pathology
Parkinson Disease
Frontotemporal Lobar Degeneration
Motor Neuron Disease
Amyotrophic Lateral Sclerosis
Brain
Ubiquitin

Keywords

  • Dementia with Lewy bodies
  • Frontotemporal lobar degeneration
  • Parkinson's disease
  • TDP-43

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., ... Trojanowski, J. Q. (2007). Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica, 114(3), 221-229. https://doi.org/10.1007/s00401-007-0261-2

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. / Nakashima-Yasuda, Hanae; Uryu, Kunihiro; Robinson, John; Xie, Sharon X.; Hurtig, Howard; Duda, John E.; Arnold, Steven E.; Siderowf, Andrew; Grossman, Murray; Leverenz, James B.; Woltjer, Randall (Randy); Lopez, Oscar L.; Hamilton, Ronald; Tsuang, Debby W.; Galasko, Douglas; Masliah, Eliezer; Kaye, Jeffrey; Clark, Christopher M.; Montine, Thomas J.; Lee, Virginia M Y; Trojanowski, John Q.

In: Acta Neuropathologica, Vol. 114, No. 3, 09.2007, p. 221-229.

Research output: Contribution to journalArticle

Nakashima-Yasuda, H, Uryu, K, Robinson, J, Xie, SX, Hurtig, H, Duda, JE, Arnold, SE, Siderowf, A, Grossman, M, Leverenz, JB, Woltjer, RR, Lopez, OL, Hamilton, R, Tsuang, DW, Galasko, D, Masliah, E, Kaye, J, Clark, CM, Montine, TJ, Lee, VMY & Trojanowski, JQ 2007, 'Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases', Acta Neuropathologica, vol. 114, no. 3, pp. 221-229. https://doi.org/10.1007/s00401-007-0261-2
Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica. 2007 Sep;114(3):221-229. https://doi.org/10.1007/s00401-007-0261-2
Nakashima-Yasuda, Hanae ; Uryu, Kunihiro ; Robinson, John ; Xie, Sharon X. ; Hurtig, Howard ; Duda, John E. ; Arnold, Steven E. ; Siderowf, Andrew ; Grossman, Murray ; Leverenz, James B. ; Woltjer, Randall (Randy) ; Lopez, Oscar L. ; Hamilton, Ronald ; Tsuang, Debby W. ; Galasko, Douglas ; Masliah, Eliezer ; Kaye, Jeffrey ; Clark, Christopher M. ; Montine, Thomas J. ; Lee, Virginia M Y ; Trojanowski, John Q. / Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. In: Acta Neuropathologica. 2007 ; Vol. 114, No. 3. pp. 221-229.
@article{a8579a6516c04d47bf1641424dd6c0f0,
title = "Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases",
abstract = "Here, we investigated if TAR-DNA-binding protein-43 (TDP-43), the disease protein in frontotemporal lobar degeneration and ubiquitin inclusions with or without motor neuron disease as well as amyotrophic lateral sclerosis, also formed inclusions in Lewy body (LB) disorders including Parkinson's disease (PD) without or with dementia (PDD), and dementia with LBs (DLB) alone or in association with Alzheimer's disease (AD). Immunohistochemical analyses of TDP-43 in clinically well characterized and pathologically confirmed cases of DLB + AD, PD and PDD demonstrated TDP-43 pathology in the following percentage of cases: DLB + AD = 25/80 (31.3{\%}); PD = 5/69 (7.2{\%}); PDD = 4/21 (19{\%}), while DLB and normal controls exhibited no (0/10, 0{\%}) and one cases (1/33, 3{\%}) presenting TDP-43 pathology, respectively. Significant differences in the prevalence of TDP-43 lesions were noted between disease versus normal brains (P <0.001) as well as demented versus non-demented brains (P <0.001). Statistical analyses revealed a positive relationship between TDP-43 lesions and several clinical and pathological parameters in these disorders suggesting the TDP-43 pathology may have co-morbid effects in LB diseases. This study expands the concept of TDP-43 proteinopathies by implicating TDP-43 lesions in mechanisms of neurodegeneration in LB disorders.",
keywords = "Dementia with Lewy bodies, Frontotemporal lobar degeneration, Parkinson's disease, TDP-43",
author = "Hanae Nakashima-Yasuda and Kunihiro Uryu and John Robinson and Xie, {Sharon X.} and Howard Hurtig and Duda, {John E.} and Arnold, {Steven E.} and Andrew Siderowf and Murray Grossman and Leverenz, {James B.} and Woltjer, {Randall (Randy)} and Lopez, {Oscar L.} and Ronald Hamilton and Tsuang, {Debby W.} and Douglas Galasko and Eliezer Masliah and Jeffrey Kaye and Clark, {Christopher M.} and Montine, {Thomas J.} and Lee, {Virginia M Y} and Trojanowski, {John Q.}",
year = "2007",
month = "9",
doi = "10.1007/s00401-007-0261-2",
language = "English (US)",
volume = "114",
pages = "221--229",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

AU - Nakashima-Yasuda, Hanae

AU - Uryu, Kunihiro

AU - Robinson, John

AU - Xie, Sharon X.

AU - Hurtig, Howard

AU - Duda, John E.

AU - Arnold, Steven E.

AU - Siderowf, Andrew

AU - Grossman, Murray

AU - Leverenz, James B.

AU - Woltjer, Randall (Randy)

AU - Lopez, Oscar L.

AU - Hamilton, Ronald

AU - Tsuang, Debby W.

AU - Galasko, Douglas

AU - Masliah, Eliezer

AU - Kaye, Jeffrey

AU - Clark, Christopher M.

AU - Montine, Thomas J.

AU - Lee, Virginia M Y

AU - Trojanowski, John Q.

PY - 2007/9

Y1 - 2007/9

N2 - Here, we investigated if TAR-DNA-binding protein-43 (TDP-43), the disease protein in frontotemporal lobar degeneration and ubiquitin inclusions with or without motor neuron disease as well as amyotrophic lateral sclerosis, also formed inclusions in Lewy body (LB) disorders including Parkinson's disease (PD) without or with dementia (PDD), and dementia with LBs (DLB) alone or in association with Alzheimer's disease (AD). Immunohistochemical analyses of TDP-43 in clinically well characterized and pathologically confirmed cases of DLB + AD, PD and PDD demonstrated TDP-43 pathology in the following percentage of cases: DLB + AD = 25/80 (31.3%); PD = 5/69 (7.2%); PDD = 4/21 (19%), while DLB and normal controls exhibited no (0/10, 0%) and one cases (1/33, 3%) presenting TDP-43 pathology, respectively. Significant differences in the prevalence of TDP-43 lesions were noted between disease versus normal brains (P <0.001) as well as demented versus non-demented brains (P <0.001). Statistical analyses revealed a positive relationship between TDP-43 lesions and several clinical and pathological parameters in these disorders suggesting the TDP-43 pathology may have co-morbid effects in LB diseases. This study expands the concept of TDP-43 proteinopathies by implicating TDP-43 lesions in mechanisms of neurodegeneration in LB disorders.

AB - Here, we investigated if TAR-DNA-binding protein-43 (TDP-43), the disease protein in frontotemporal lobar degeneration and ubiquitin inclusions with or without motor neuron disease as well as amyotrophic lateral sclerosis, also formed inclusions in Lewy body (LB) disorders including Parkinson's disease (PD) without or with dementia (PDD), and dementia with LBs (DLB) alone or in association with Alzheimer's disease (AD). Immunohistochemical analyses of TDP-43 in clinically well characterized and pathologically confirmed cases of DLB + AD, PD and PDD demonstrated TDP-43 pathology in the following percentage of cases: DLB + AD = 25/80 (31.3%); PD = 5/69 (7.2%); PDD = 4/21 (19%), while DLB and normal controls exhibited no (0/10, 0%) and one cases (1/33, 3%) presenting TDP-43 pathology, respectively. Significant differences in the prevalence of TDP-43 lesions were noted between disease versus normal brains (P <0.001) as well as demented versus non-demented brains (P <0.001). Statistical analyses revealed a positive relationship between TDP-43 lesions and several clinical and pathological parameters in these disorders suggesting the TDP-43 pathology may have co-morbid effects in LB diseases. This study expands the concept of TDP-43 proteinopathies by implicating TDP-43 lesions in mechanisms of neurodegeneration in LB disorders.

KW - Dementia with Lewy bodies

KW - Frontotemporal lobar degeneration

KW - Parkinson's disease

KW - TDP-43

UR - http://www.scopus.com/inward/record.url?scp=34547733547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547733547&partnerID=8YFLogxK

U2 - 10.1007/s00401-007-0261-2

DO - 10.1007/s00401-007-0261-2

M3 - Article

C2 - 17653732

AN - SCOPUS:34547733547

VL - 114

SP - 221

EP - 229

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 3

ER -